The Uromigos podcast

Episode 536 - Uromigos Live 2026 – High-risk Localized Prostate Cancer

11/14/2026
0:00
48:53
Rewind 15 seconds
Fast Forward 15 seconds

Several phase 3 trials in high-risk localized prostate cancer have reported this year including PROTEUS and DASL. The panel debates if and how these will impact treatment of this patient population.

More episodes from "The Uromigos"